开普拓

开普拓（CPT-11）治疗中国人晚期大肠癌初步结果

Preliminary Result of Irinotecan ( CPT-11 ) in the Treatment of Chinese Patients with Advanced Colorectal Cancer

开普拓联合5-FU治疗5-FU耐药的晚期大肠癌

Effects of camptothecin plus 5-FU in treating patients with 5-FU resistant advanced colorectal cancer

目的观察开普拓（CPT11）联合5-氟尿嘧啶（5FU）治疗5FU耐药晚期大肠癌的效果。

Objective To investigate the effects of camptothecin ( CPT 11 ) plus 5 FU in treating patients with 5 FU resistant advanced colorectal cancer .

在晚期胃癌的临床研究中，泰索帝和开普拓（CPT-11）比奥沙利铂、S-1和其他正在进行早期研究的新药显得更有发展前景。

Taxotere and CPT-11 appear to hold more promise in the investigation of patients with AGC than drugs like oxaliplatin , S-1 , or many new classes of compounds that are under early investigation .

开普拓对人宫颈癌荷瘤裸鼠放射增敏作用的实验研究

Radiosensitizing effect of CPT-11 on cervical carcinoma transplanted tumor in nude mice

开普拓的各种联合化疗方案均显示了相当好的缓解率。

Various combinations of CPT-11 have been studied resulting in a very decent response rate .